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Neurobiology of Disease
A Rapamycin-Sensitive Signaling Pathway Is Essential for
the Full Expression of Persistent Pain States
Sandrine M. Ge´ranton,1* Lydia Jime´nez-Díaz,1,4* Carole Torsney,2 Keri K. Tochiki,1 Sarah A. Stuart,1 J. Lianne Leith,3
Bridget M. Lumb,3 and Stephen P. Hunt1
1Department of Cell and Developmental Biology, University College London, LondonWC1E 6BT, United Kingdom, 2Centre for Integrative Physiology,
The University of Edinburgh, Edinburgh EH8 9XD, United Kingdom, 3Department of Physiology, University of Bristol, Bristol BS8 1TD, United Kingdom,
and 4Departamento Fisiología, Facultad Medicina, Instituto Neurociencias Castilla y Leo´n, Universidad de Salamanca, Salamanca 37007, Spain
Translational control through the mammalian target of rapamycin (mTOR) is critical for synaptic plasticity, cell growth, and axon
guidance. Recently, it was also shown thatmTOR signalingwas essential for themaintenance of the sensitivity of subsets of adult sensory
neurons. Here, we show that persistent pain states, but not acute pain behavior, are substantially alleviated by centrally administered
rapamycin, an inhibitor of the mTOR pathway. We demonstrate that rapamycin modulates nociception by acting on subsets of primary
afferents and superficial dorsal horn neurons to reduce both primary afferent sensitivity and central plasticity. We found that the active
form ofmTOR is present in a subpopulation ofmyelinated dorsal root axons, but rarely in unmyelinated C-fibers, and heavily expressed
in the dorsal hornby lamina I/III projectionneurons that are known tomediate the induction andmaintenance of pain states. Intrathecal
injections of rapamycin inhibited the activation of downstream targets ofmTOR in dorsal horn anddorsal roots and reduced the thermal
sensitivity of A-fibers. Moreover, in vitro studies showed that rapamycin increased the electrical activation threshold of A-fibers in dorsal
roots.Together,ourresults imply thatcentral rapamycinreducesneuropathicpainbyactingbothonanmTOR-positivesubsetofA-nociceptors
and lamina I projection neurons and suggest a newpharmacological route for therapeutic intervention in persistent pain states.
Introduction
Local activity-dependent protein translation within dendrites,
regulated by the kinasemTOR, themammalian target of rapamy-
cin, plays a critical role in the modulation of long term plasticity
and memory processes (Zheng et al., 2001; Hanz et al., 2003;
Klann and Dever, 2004; Willis et al., 2005; Murashov et al., 2007;
Costa-Mattioli et al., 2009). Activation ofmTOR complexedwith
the protein raptor (mTORC1) promotes the phosphorylation of
mTOR downstream targets, 4E-BP1/2 and S6K. mTORC1 regu-
lates cap-dependent translation of some growth related mRNAs
(Gingras et al., 1999) via 4E-BP1/2 phosphorylation and the
translation of a subset ofmRNAs that contain an oligopyrimidine
tract in their 5 end (TOP mRNAs) via S6K phosphorylation
(Ruvinsky and Meyuhas, 2006; Costa-Mattioli et al., 2009). TOP
mRNAs largely encode components of the translational machin-
ery, including ribosomal proteins and elongation factors. Dele-
tion of either 4E-BP1/2 and S6K gene inmice results in deficits in
synaptic plasticity and long-term memory (Banko et al., 2005;
Antion et al., 2008; Costa-Mattioli et al., 2009).
Recently, the contribution of mTOR to axonal regeneration
and growth has been recognized and ribosomes (Koenig andGiu-
ditta, 1999; Alvarez, 2001; Martin, 2004; Koenig, 2009), mRNAs
(Zheng et al., 2001; Willis et al., 2005), and the enzymatic ma-
chinery involved in the regulation of translation (Hengst et al.,
2006; Murashov et al., 2007) have been localized to the axonal
compartment (Price and Ge´ranton, 2009). Most previous re-
search has concentrated on the role of local translation in dam-
aged or developing axons. For example, peripheral nerve injury
was shown to induce the axonal transport of mRNAs into dam-
aged fibers to promote regeneration (Verma et al., 2005;Willis et
al., 2005; Toth et al., 2009) as well as the local synthesis of NaV1.8
sodium channel that may be responsible for the increased sensi-
tivity of injured nerve fibers (Thakor et al., 2009).
However, we have recently shown that the sensitivity of some
primary afferents can be regulated locally throughmTORC1 signal-
ing (Jime´nez-Díaz et al., 2008). Injury is followed by the spread of
sensitivity into undamaged areas around the site of injury (second-
ary hyperalgesia). This is generated by changes in the superficial
dorsal horn that lead to the amplificationof the responseof a specific
subset of capsaicin-insensitive primary afferent A-fibers (Magerl et
al., 2001). It is the sensitivity of this population of sensory fibers that
ismaintainedperipherally by the tonically activemTORC1signaling
pathway (Jime´nez-Díaz et al., 2008). Moreover, in this study, rapa-
mycin, which specifically inhibitsmTORC1 signaling, was shown to
reduce the increased mechanical sensitivity seen in a neuropathic
painmodel when injected in the hindpaw.
The central application of rapamycin intrathecally over the
spinal cord has received some attention and both rapamycin and
Received July 17, 2009; revised Oct. 15, 2009; accepted Oct. 23, 2009.
Thisworkwas supported by grants from theWellcome Trust (080506 and 085566), theMedical Research Council
(G0801381), the Caledonian Research Foundation (R39726), the Biotechnology and Biological Sciences Research
Council (G012717), and the Spanish Ministerio de Educación y Ciencia (JCI-2005-1775-25). We thank Peter Brophy
for the neurofascin antibody and for helpful discussion during the preparation of this manuscript.
*S.M.G. and L.J.-D. contributed equally to this work.
Correspondence should be addressed to either SandrineM. Ge´ranton or BridgetM. Lumb at the above addresses.
E-mail: ucgasmg@ucl.ac.uk or B.M.Lumb@bristol.ac.uk.
DOI:10.1523/JNEUROSCI.3451-09.2009
Copyright © 2009 Society for Neuroscience 0270-6474/09/2915017-11$15.00/0
The Journal of Neuroscience, November 25, 2009 • 29(47):15017–15027 • 15017
anisomycin (Kim et al., 1998; Price et al., 2007; Asante et al.,
2009) have been shown to reduce formalin-induced pain-related
behavior. This was thought to reflect the loss of synaptic plasticity
that underlies central sensitization of dorsal horn neurons and
accompanies injury and that has been mainly attributed to the
inhibition of protein synthesis in spinal neurons. However, it
seems likely that reduced mTORC1 activity in the central processes
of sensory neurons could also contribute to the attenuation of pain
behavior. Here, we examine the subcellular distribution and func-
tion of activated mTORC1 in the dorsal horn and dorsal roots and
conclude that intrathecal rapamycin has effects at both sites, result-
ing in a profound reduction in neuropathic pain sensitivity.
Materials andMethods
Subjects
All procedures complied with the UK Animals (Scientific Procedures)
Act 1986. Male Sprague Dawley rats [170–200 g; Central Biological Ser-
vices, University College London, London, UK; postnatal day 18–21
(P18–P21), University of Edinburgh Biological Services, Edinburgh,
UK], group housed 5 per cage, were used for all experiments except for
electromyographic (EMG) studies whenmaleWistar rats (280–310 g; Uni-
versity of Bristol, Bristol, UK) were used. Animals were kept in their home
cages at 21°C and 55% relative humidity with a light–dark cycle of 12 h
(lights on at 08:00 A.M.). Food and water were provided ad libitum. All
effortsweremade tominimize animal suffering and to reduce thenumberof
animals used.
Behavioral experiments
In all experiments, the observer was blinded to the intrathecal (vehicle vs
rapamycin) treatment. Each animalwas assigned toonebehavioral test only;
i.e., was never tested inmore thanonemodality, apart from the sparednerve
injury (SNI) groups where Von Frey testing was followed by pinprick.
Mechanical stimulation
Von Frey test. A series of calibrated Von Frey hairs were applied to the
plantar surface of the paw, in ascending order. The thresholdwas taken as
the lowest force required to elicit a response to one of five repetitive
stimuli.
Pinprick test.The point of a safety pinwas applied to the plantar surface
of the paw at an intensity sufficient to indent but not penetrate the skin.
The duration of pawwithdrawal was recordedwith aminimum arbitrary
value of 0.5 s for a brief normal response and a maximum cutoff of 10 s.
Thermal stimulation
Thermal withdrawal latencies were determined as described pre-
viously (Hargreaves et al., 1988); four readings were collected
from each paw.Withdrawal latencies were defined as themean of
the four readings.
Antibodies and drugs
Anti-phospho-mTOR [P-mTOR, Ser2448; used at a concentration of
1:1000 for immunohistochemistry; catalog number (Cat. No.): 2971],
anti-mTOR (1:1000; Cat. No.: 2972), anti-phospho-4E-BP1/2 (P-4E-
BP1/2, Thr37/46; 1:1000; Cat. No.: 9459), anti-4E-BP1/2 (1:1000; Cat.
No.: 9452), anti-phospho-S6 (P-S6, Ser235/236; 1:1000; Cat. No.: 2211),
and anti-S6 (1:1000; Cat. No.: 2217) antibodies were obtained from Cell
Signaling Technology. The anti-protein gene product 9.5 antibody (PGP;
1:500; Cat. No.: RA95101 was obtained from Ultraclone. The antibody to
mouse anti-neurofilament 200 kDa clone N52 (N52; 1:2000; Cat. No.:
N0142) was obtained from Sigma. Anti c-Fos antibody (1:60,000) was ob-
tained fromCalbiochemand the anti-peripherin (1:250,Cat.No.: 1530) and
anti-Gapdh antibodies from Millipore Bioscience Research Reagents. The
antibody against neurofascin (Sherman et al., 2005) (Nfc2) was a gift from
Peter Brophy (University of Edinburgh, Edinburgh, UK). Both Fluorogold
and the antibody against Fluorogold (1:25,000) were purchased from Fluo-
rochrome. Finally, N-vanillylnonanamide (synthetic capsaicin) was pur-
chased from Sigma and rapamycin from LC Laboratories.
Intraplantar injections of capsaicin
N-Vanillylnonanamide (synthetic capsaicin) solution was made up at a
concentration of 10mM in a vehicle of saline containing 10% ethanol and
10%Tween 80. All injections were given in a volume of 10l. To prepare
for the injection, rats were gently wrapped in a cotton towel with the left
hindpaw exposed. During the injection the needle penetrated the skin
just distal to the targeted area which was the center of the plantar surface
of the left hindpaw. Care was taken to deliver each injection superficially
into the skin. Injection of capsaicin, but not of the vehicle, produced
immediate “nocifensive” behavior (lifting, licking, and/or shaking of the
paw) that lasted 1–3 min.
Spared nerve injury surgery
The SNI was performed as described previously (Decosterd and Woolf,
2000). The common peroneal and tibial nerves were tightly ligated with 5.0
silk and sectioned distal to the ligation. Care was taken to avoid touching or
stretching the spared sural nerve. For sham surgery, the sciatic nerve was
exposed but no contact was made with the nerve. Behavioral testing began
48 h after surgery and continued for 6 d postsurgery.
Intrathecal injection of rapamycin (for behavioral studies
and immunochemistry)
Dose and pretreatment times were optimized in a previous study
(Jime´nez-Díaz et al., 2008). Under isoflurane anesthesia [1.5–2% isoflu-
rane combined with 100%O2 (1l/min)], rats were placed in a stereotaxic
frame and a small incision was made in the atlanto-occipital membrane.
A cannula was inserted into the subarachnoid space, terminating in L4–5
region. Animals received either 10 l of rapamycin (250 M, 2.3 g) or
vehicle (saline containing 20% ethanol). The cannula was then with-
drawn and the wound closed with suture clips.
Electrophysiology
Electromyographic dissociation of A- and C-fiber responses. A-fiber (my-
elinated, capsaicin-insensitive) heat nociceptors or C-fiber (unmyeli-
nated, capsaicin-sensitive) heat nociceptors on the dorsal surface of the
hindpaw were preferentially stimulated via fast (7.5 1°C s1) or slow
(2.5  1°C s1) rates of heating, respectively, using a constant bulb
voltage as described previously (McMullan et al., 2004; Jime´nez-Díaz et
al., 2008). The cutoff temperature of the heat lamp was controlled via a
Spike2 script to prevent tissue damage. Alternating fast and slow heat
ramps were performed at 8 min intervals and threshold temperature at
which the withdrawal reflex occurred recorded. Intrathecal injection of
2.3 g of rapamycin or the vehicle was made once a steady baseline of
paw withdrawal thresholds had been achieved, without disconnecting
the animal from the set up. Fast and slow heat ramps were resumed and
paw withdrawal thresholds measured: a “pair” of fast and slow heat
rampswas performed every 30min, with an 8min interstimulus interval,
and continued for 6 h postinjection.
Extracellular compound action potential recording from dorsal roots.
Unsexed rats (P18–P21) were anesthetized with isoflurane, decapitated,
and lumbar (L4/L5) dorsal roots, without dorsal root ganglion, were
removed and placed in ice-cold dissection solution. Isolated roots were
preincubated in 200 nM rapamycin (Tang et al., 2002; Ehninger et al.,
2008) or vehicle (0.1% DMSO in oxygenated recovery solution) for at
least 2.5 h before recording (initially at 3637°C for 1 h then at room
temperature). Roots were transferred to a recording chamber and con-
tinuously perfused with 200 nM rapamycin or vehicle (0.1% DMSO in
oxygenated Krebs) at a flow rate of 1–2 ml/min and recordings were
made at room temperature. SaturatedKrebs solution in 95%O2/5%CO2
had the following composition (in mM): 125 NaCl, 2.5 KCl, 1.25
NaH2PO4, 26 NaHCO3, 25 glucose, 1 MgCl2, 2 CaCl2, pH 7.4. Recovery
solution was the same as Krebs but with 1.5 CaCl2 plus 6 MgCl2. Dissec-
tion solution was the same as recovery but with 1 mM kynurenic acid.
Two suction electrodes were used: one for electrical stimulation of the
root and the other for recording compound action potentials. Electrical
stimulation (10) was performed at 0.2 Hz for 0.1 ms using an ISO-Flex
Stimulus Isolator (A.M.P.I., Intracel). The stimulation intensities used
were (in A) 1, 2, 3, 4, 5, 7.5, 10, 15, 20, 25 for A-, 30–100 (in incre-
ments of 10) for A- and 150–500 (in increments of 50) for C-fiber input
(Nakatsuka et al., 2000). Data were recorded and acquired using a Cygnus
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ER-1 differential amplifier (Cygnus Technology) and pClamp 10 software
(Molecular Devices). Data were filtered at 10 kHz and sampled at 50 kHz.
Three main components of the compound action potentials could be
distinguished; fast (A/-), medium (A-) and slow (C-) conducting
components, each having a triphasic (positive-negative-positive) profile.
Sometimes small intermediate components were present among these
three groups but these were not analyzed. The threshold of each compo-
nent was defined as the lowest stimulation intensity at which the negative
component was clearly discernible. The amplitude of each component
was calculated by measuring the distance between the negative and pos-
itive peaks and the conduction velocity was calculated based on the la-
tency to the negative peak at 25, 100, and 500 A for A/-, A-, and
C-components, respectively.
Retrograde labeling of dorsal horn projection neurons
To label projection neurons in the dorsal horn, a retrograde marker,
Fluorogold (FG, 4%, 300 nl) was injected into the parabrachial area
(Ge´ranton et al., 2007) of adult rats. Rats were placed in a Kopf stereo-
taxic frame under isoflurane anesthesia and a small incision was made in
the scalp to expose the skull and reveal bregma. Following craniotomy,
animals received an injection of Fluorogold into the parabrachial area
(mm: AP 9.2, ML 1.7, DV 6.4, both sides) (Paxinos et al., 1985)
delivered by a Hamilton syringe of a total volume of 2.5 l. Rats were
allowed to recover from anesthesia in an incubation chamber and then
transferred back to their home cage for 3 d.On the third day after surgery,
rats were perfused, as described below.
Immunohistochemistry
For immunohistochemistry, rats were deeply anesthetized with pento-
barbital and perfused transcardially. The spinal cord, and dorsal roots
were dissected out, postfixed in the same PFA solution for 2 h and trans-
ferred into a 30% sucrose solution in PB containing 0.01% azide, until
further processing and for a minimum of 24 h. Tissue was cut on a
freezing microtome at 40 m. A tyramide signal amplification based
protocol was followed for all primary antibodies apart from c-Fos
(Jime´nez-Díaz et al., 2008). For double labeling with PGP, N52, Nfc2,
peripherin and Fluorogold antibody, P-mTOR (as well as P-S6 and
P-4EBP1/2) labeled sections were left overnight in a solution of PGP
(1:500), N52 (1:2000), Nfc2 (1:3000), peripherin (1:250) or Fluorogold
antibody (1:25,000) and processed as before (Ge´ranton et al., 2007;
Jime´nez-Díaz et al., 2008).
For c-Fos immunohistochemistry, sections were incubated for 1 h in
3% normal goat serum, 0.3% Triton X-100 and 0.6% of hydrogen per-
oxide in 0.1 M PB. Then, sections were incubated overnight in a rabbit
polyclonal antibody anti-c-Fos (1:60,000; Ab-5; Calbiochem). Sections
were washed in 0.1 M PB and incubated for 1 h in a goat anti-rabbit
biotinylated antibody (Vector Laboratories; 1:500). Sections were
washed again and incubated for 2 h in avidin-biotin peroxidase complex
(ABC Elite; Vectastain, Vector Laboratories). Following washes, sections
were incubated for 5 min in a solution containing 0.05% of 3,3 diami-
nobenzidine (DAB) and 0.2% ammonium nickel sulfate in H2O. The
reaction was stopped by washes in H2O and then PB and sections were
mounted on gelatin-coated slides and coverslipped.
Controls included omission of the first or second primary antibodies
or addition of blocking peptideswhen available (P-mTORandP-S6).We
also confirmed antibody specificity by Western blot. Single or double
bands of appropriatemolecular weight were found formTOR, P-mTOR,
4E-BP1/2, P-4E-BP1/2 and S6 and P-S6 protein.
Cell counting
To count the number of c-Fos-labeled and P-S6-labeled cells, the super-
ficial dorsal horn was divided into three ipsilateral domains: the superfi-
cial laminae I-II, laminae III-IV and the deep laminaeV-VII. For each rat,
Fos- or P-S6 immunoreactive (Fos-IR or P-S6-IR) neurons counted in
the 3–5 most labeled sections were averaged, and the mean was used for
further statistical analysis.
Image analysis and quantification of immunofluorescence
All images of double stained tissuewere acquired by confocalmicroscopy
using a laser scanningmicroscope (Leica TCSNT SP) as described before
(Jime´nez-Díaz et al., 2008). Postacquisition processing was performed
with Adobe Photoshop and Adobe Illustrator.
Tissue collection and immunoblotting
For fresh tissue collection, animals were terminally anesthetized with
CO2. The L4, L5 and L6 dorsal roots ganglia (DRGs), their central pro-
cesses proximal to the spinal cord and the superficial dorsal horn L4-L6
were dissected out and frozen on dry ice in three separate collecting
tubes. Samples were then stored at – 80°C until further processing. For
protein extraction, one dorsal horn samplewas homogenized in 500l of
lysis buffer, DRGs (6 DRGs per sample) in 200l of lysis buffer as well as
the corresponding dorsal roots (six 0.5 cm root sections corresponding to
L4, L5 and L6, proximal to the cord) and incubated on ice for 2 h.
Samples were then centrifuged at 13 000 rpm for 15 min and superna-
tants collected. Total protein concentration was assessed using a bicin-
choninic acid (BCA) protein assay kit (Pierce Biotechnology) before each
preparation of protein samples. Samples (20 g of proteins per well for
spinal cord and 30 g of proteins per well for DRGs and roots) were run
on 10% Bis-Tris gels (Biorad Laboratories) for detection of P-4E-BP1/2,
4E-BP1/2, P-S6 and S6 protein. Proteins were transferred onto a PVDF
membrane (Biorad). Membranes were blocked and incubated. HRP ac-
tivity was visualized by applying a chemiluminescent substrate (ECL; GE
Healthcare Pharmacia Biotech) and using Chemi Doc XRS from Biorad.
Membranes were then washed and incubated with Gapdh antibody (1:
1000) for 45min, and further processed as described above. Signal inten-
sity was measured using Quantity One software (Biorad). For each
sample and each membrane signal for P-4E-BP1/2, 4E-BP1/2, P-S6 and
S6 protein was normalized with the intensity of the corresponding
Gapdh signal. The signal for each phosphorylated antibody was then
normalized with that of the corresponding antibody for the total protein
(except for the roots samples where the signal for S6 protein was too
weak). The mean value obtained for the vehicle treatment at 30 min was
arbitrarily set at 100%. For an extra confirmation of equal loading of
proteins, membranes were stained with Coomassie dye and staining of
the wells visually compared.
Statistical data analysis
All statistical tests were performed in SPSS PC. Repeated-measures
ANOVA followed by Tukey or Bonferroni post hoc analysis where appro-
priate was used to analyze all behavioral data, including EMG studies.
The Greenhouse–Geisser ‘’ correction was applied to compensate for
any violation of sphericity. If the Levene’s test for normal distribution
was significant then data were normalized by logarithmic (log2) trans-
formation. Data were always analyzed as presented in the figures (raw
data or log2 transformed). For the compound action potential experi-
ments, threshold values for the activation of fibers were compared by
Student’s t test within each fiber group. For cell counting, the number of
labeled cells was analyzed by univariate analysis. For Western blots, nor-
malized signals were compared in vehicle- and rapamycin-treated ani-
mals by a Student’s t test (4E-BP1/2, P-4E-BP1/2) or multivariate
analysis followed by appropriate post hoc tests (S6, P-S6 protein).
Results
Acute nociceptive thresholds and primary sensitization are
not influenced by intrathecal injection of rapamycin
Injection of capsaicin produces peripheral sensitization of C- and
some A-nociceptors and drives the central sensitization of dor-
sal horn neurons. Here we show that sensory neurons response to
capsaicin stimulation is unaffected by rapamycin pretreatment.
First, thermal and mechanical thresholds were monitored
1–24 h after intrathecal administration of rapamycin (10 l of
250 M, i.e., 2.3 g) into the lumbar spinal cord (Fig. 1). Rapa-
mycin (or vehicle) did not modify thermal (Fig. 1A1) and me-
chanical (Fig. 1B1, C1) thresholds at any time point.
We thenmeasured the effects of rapamycin on the development
of thermal primary hyperalgesia that follows capsaicin injections
into the paw. Rapamycin was given 4 h before subsequent treat-
ments. Capsaicin on its own increased thermal sensitivity (i.e., in-
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duced primary hyperalgesia) for up to 35
min after intraplantar injection. No signifi-
cant changes in withdrawal latency were
seen in the contralateral hindpaw (Jime´nez-
Díaz et al., 2008). Intrathecal pretreatment
withrapamycinorvehicle4hbeforecapsaicin
did not change the increased thermal sensi-
tivity that follows capsaicin injection (Fig.
1A2).
The effects of intrathecally adminis-
tered rapamycin on the C-fibers activa-
tion by capsaicin injection were studied
with c-Fos immunoreactivity (c-Fos-IR).
Fos expression has beenwidely used tomap
neuronal activity within nociceptive path-
ways (Hunt et al., 1987). c-Fos-IR was ana-
lyzed 2 h after capsaicin injection which
occurred 4 h after the intrathecal adminis-
tration of rapamycin or vehicle. Capsaicin
injection induced the expected pattern of
c-Fos expression in the dorsal horn but
there was no difference between rapamycin
and vehicle pretreated animals in any of the
three ipsilateral lamina domains studied
(supplemental Fig. S1, available at www.
jneurosci.org as supplemental material).
Together, these results suggest that the cap-
saicin induced stimulation of C-fiber noci-
ceptors is not modulated by rapamycin.
Intrathecally administered rapamycin
blocks the spread of hypersensitivity
into undamaged cutaneous areas
(secondary mechanical hyperalgesia)
The increased mechanical sensitivity that
occurs around the area of capsaicin injec-
tion (secondary mechanical hyperalge-
sia) is mainly mediated by a subset of
capsaicin-insensitive A-nociceptors, the
response of which is amplified by sensi-
tized dorsal horn neurons (Magerl et al.,
2001; Jime´nez-Díaz et al., 2008). Here we
show that rapamycin specifically reduces
this secondary hyperalgesia.
To determine response thresholds,
both Von Frey hairs, which cover the
spectrum of both A- and C-fiber mechan-
ical response thresholds, and pinprick
test, a more specific stimulus for A-fiber
nociceptors, were used.
Von Frey hair testing
Intrathecal injection of rapamycin 4 h before capsaicin injection
reduced the capsaicin induced secondary hyperalgesia from 5
min to 2 h after capsaicin (F(1,12)  14.4, p  0.01 vs vehicle
pretreatment) (Fig. 1B2).
Response to pinprick
To confirm that secondary mechanical hyperalgesia can be
largely abolished by rapamycin pretreatment we examined the
response to pinprick, a more specific stimulus for A-fiber noci-
ceptors (Magerl et al., 2001). Capsaicin alone increased with-
drawal duration to the pinprick stimulus in the area of secondary
hyperalgesia for up to 2 h after intraplantar injection. Intrathecal
administration of rapamycin 4 h before capsaicin injection
greatly reduced capsaicin-induced secondary hyperalgesia (Fig.
1C2) (F(1,17) 7.5, p 0.05 vs vehicle pretreatment).
Rapamycin reduces mechanical sensitivity in a rat model of
chronic pain
Wenext show that neuropathic pain, that sharesmany featureswith
secondary hyperalgesia (Pertovaara, 1998; Urban and Gebhart,
1999), is also alleviated by central rapamycin treatment.
Following SNI, rats showed an enhanced response to Von Frey
and pinprick stimulation in the lateral part of the hindpaw, the sural
territory, from day 2 to day 6 after surgery (Fig. 2A,B). On day 6,
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Figure 1. Intrathecal administration of rapamycin does not affect acute pain but reduces capsaicin-induced secondary but not
primary hyperalgesia. A1, B1, C1, Effects of intrathecal injection of rapamycin (or vehicle) in naive rats on the following: with-
drawal latency to heat using the Hargreaves test (A1;N 6 in each group),mechanical withdrawal thresholdmeasuredwith Von
Frey hairs (B1; N  8 in each group), and withdrawal response duration after nociceptive mechanical stimulation (pinprick
stimulus) of the plantar surface of the paw (C1;N 4 in each group). A2,B2, C2, Rapamycin (or vehicle) was delivered 4 h before
the administration of capsaicin in the center of the plantar surface of the paw. Effects of intrathecal injection of rapamycin (or
vehicle) on the following: withdrawal latency to heat after capsaicin (A2, N 6 in each group), lateral mechanical withdrawal
threshold after capsaicin injection measured with Von Frey hairs (B2, N 7 in each group), withdrawal response duration to
lateral pinprick stimulationafter capsaicin (C2,N9–10).MeanSEMfor the injected (left) hindpaw is illustrated ineachpanel.
*p 0.05, **p 0.01.
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animals received an intrathecal injection of 2.3 g of rapamycin or
vehicle.
Von Frey hair testing
Rapamycin treatment resulted in a substantial increase in me-
chanical thresholds 4–24 h postinjection when compared with
vehicle treatment ( post hoc SNI rapamycin vs SNI vehicle
F(1,13) 17.5; p 0.001) (Fig. 2A), with a maximum reduction
seen at 4 h.With a single time point post hoc analysis, the effects of
rapamycin were significant at both the 4 and 24 h time points
( p 0.01 at both time points).
Response to pinprick
Rapamycin treatment resulted in a decrease in the amount of
time the animals were holding up their paw following pricking
stimulation, 4 –24 h postinjection, when compared with vehi-
cle treatment ( post hoc SNI rapamycin vs SNI vehicle F(1,13)
7.8; p 0.05) (Fig. 2B), with a maximum reduction compared
to vehicle of 61% seen at 4 h. With a single time point post hoc
analysis, the effects of rapamycin were significant at both the 4
and 24 h time points ( p  0.05 at both time points).
Rapamycin increases the thermal and electrical threshold of
activation of A-fibers
Our results show that intrathecally delivered rapamycin can reduce
themechanical sensitivity seenboth inundamaged tissuearound the
site of injury and in a model of neuropathic pain. We next investi-
gated the effects of intrathecal administration of rapamycin on the
thermal sensitivity of A- and C-fibers in experiments that preferen-
tially activateA- andC-fiber heat nociceptors.Wealsomeasured the
Figure3. Intrathecal administrationof rapamycin increasesA-butnotC-nociceptor-evokedpaw
withdrawal thresholds. Time course effects of intrathecal injection of rapamycin or vehicle on paw
withdrawal thresholds to fast and slow heat ramps that preferentially activate A- and C-nociceptors
respectively.N3 in eachgroup.Mean SEMheatwithdrawal threshold (°C) is illustrated in each
panel. Vertical dashed line indicates the drug injection time. *p 0.05; **p 0.01.
Aα/β
Aδ C
1mV
2ms
Figure 4. Extracellular compound action potential recordings. Representative compound
action potentials recorded from an isolated rapamycin-treated dorsal root illustrating the fast
(A/-), medium (A-) and slow (C-) conducting components evoked by 500A stimulation
(average of 10 traces shown). Arrows indicate the negative peak of each triphasic (positive-
negative-positive) profile. In this example the last positive peak of the A-component overlaps
the first positive peak of the C-component. The threshold stimulation intensities for theA/-,
A-, and C-fiber components were 5, 60, and 200A, respectively.
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Figure 2. Intrathecal administration of rapamycin attenuates mechanical hyperalgesia in
the SNI model. Effect of intrathecal injection of rapamycin, or its vehicle on, A, mechanical
withdrawal threshold measured with Von Frey hairs, and B, withdrawal response duration (s)
after nociceptivemechanical stimulation (pinprick stimulus) of the lateral plantar surface of the
paw of SNI animals, or sham animals. Mean SEM is illustrated. N 3–4 in sham groups,
N 7–8 in SNI groups. *p 0.05, ***p 0.001.
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effect of rapamycin on the electrical activa-
tion threshold of C-, A-, and A-fibers in
vitro.We showthat the sensitivityof a subset
of A-fibers is reduced by intrathecal
rapamycin.
Heat-responsiveandcapsaicin-insensitive
A-nociceptors (that mediate secondary hy-
peralgesia, i.e., the spread of pain sensitivity
around the site of injury) are preferentially
activated by a fast heat ramp, whereas
C-fibers respondonly toa slowerheat ramp
(McMullan et al., 2004; Leith et al., 2007).
Intrathecal injection of rapamycin signifi-
cantly increased threshold temperatures for
paw withdrawal evoked by fast heat ramps
(activating A-fiber nociceptors) from 150
min postinjection, compared to control in-
jections of vehicle (Fig. 3) ( p 0.05, Bon-
ferroni post hoc test). In contrast, paw
withdrawal thresholds to slow heat ramps
(activating C-fiber nociceptors) remained
unchanged after rapamycin (Fig. 3).
Primary afferents could be divided
into three distinct groups, corresponding
to A/-, A-, and C-fibers, on the basis
of threshold and conduction velocity of
compound action potentials recorded ex-
tracellularly from the dorsal root (Fig. 4).
Rapamycin treatment of isolated dorsal
roots (incubation in 200 nM solution) sig-
nificantly increased the threshold stimu-
lation intensity required to activate the
A-component, compared to vehicle-
treated roots (vehicle: 47.1  5.7 A,
rapamycin: 67.5  5.3 A; p  0.05, un-
paired t test). In contrast, there was no
significant difference in the threshold val-
ues for activation of the A/-component
(vehicle: 4.4  0.2 A, rapamycin: 4.8 
0.4 A) or the C-component (vehicle:
171.4  10.10, rapamycin: 187.5  15.7
A). The conduction velocity of the
A/- (vehicle: 4.4 0.3 m/s, rapamycin:
4.6  0.4 m/s), the A- (vehicle: 0.5 
0.08, rapamycin: 0.4  0.01), and the
C- (vehicle: 0.2 0.004, rapamycin: 0.2
0.008) fiber components were not significantly altered by rapa-
mycin treatment, and are similar to comparable in vitro
recordings (Labrakakis et al., 2003). The amplitudes of the A/-
(vehicle: 4.3 1.2, rapamycin: 4.3 1.0), the A- (vehicle: 0.1
0.01, rapamycin 0.2 1.0), and the C- (vehicle: 0.3 0.07, rapa-
mycin 0.3 0.04) fiber components were also unaltered by rapa-
mycin treatment.
mTOR is present in primary afferent fibers in dorsal roots but
not in primary afferent central terminals
Together, our results strongly suggest that localmTORC1 activity
regulates the sensitivity of a subset of A-fibers within dorsal
roots.We therefore used immunochemical techniques to localize
mTOR within dorsal roots and measured the effects of intrathe-
cally administered rapamycin on mTORC1 activity in the roots,
spinal cord, and DRG cells.
Immunohistochemical staining of sections of adult rat dor-
sal roots showed that mTOR and P-mTOR were extensively
expressed in subsets of primary afferent sensory fibers as well
as in non-neuronal cells of surrounding tissue (Fig. 5). Sen-
sory fibers were identified from costaining with PGP, a general
marker for sensory afferents, N52, a specific marker for my-
elinated fibers and peripherin, a marker for small fibers. The
majority of P-mTOR labeled fibers were N52 positive, implying
that P-mTORwas largely restricted tomyelinated A-fibers. How-
ever, a small number of peripherin-positive fibers (5% of
peripherin-positive fibers) were also seen. This may imply ex-
pression of mTOR in some C-fibers (Fig. 5D,E), although pe-
ripherin also labels small myelinated fibers (Ferri et al., 1990).
P-mTOR labeling was found within 40% of myelinated axons
and was continuous for hundreds of micrometers or could also
appear as accumulations along the nerve fibers. Costaining with
the neurofascin antibody Nfc2, which labels both axonal (nodal)
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Figure 5. P-mTOR immunoreactivity in dorsal roots is largely found within myelinated fibers. A–F, Confocal images of longi-
tudinal sections of dorsal roots. A, Colocalization of P-mTOR (green) andmyelinated fiber marker N52 (red).B, C, Colocalization of
P-mTOR (green) and nerve fibersmarker PGP (red), a generalmarker of nerve fibers. P-mTOR staining can be seen along the nerve
fibers (arrows) but also in accumulations along the fibers (arrow heads). D, E, Colocalization of P-mTOR (green) and peripherin
(red), a marker for small fibers. F, Colocalization of P-mTOR (green) and neurofascin (red), a marker for nodes and paranodes.
Axonal accumulations of P-mTOR (arrow head) can be seen in association with nodes of Ranvier but in some cases also localized
adjacent to the Schmidt-Lanterman incisures (arrow) of the surrounding Schwann cells. G, Confocal images of horizontal sections
of dorsal horn. Pictures show P-mTOR (green) andmyelinated fiber marker N52 (red). P-mTOR staining in sensory axons does not
extend beyond the dorsal root entry zone (arrow). In A–G the single staining for each antibody and themerged image are shown
from left to right and double staining appears in yellow.A–F, Single plane picture. Scale bars:A–E, 25m; F, 50m;G, 100m.
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and glial (paranodal) neurofascins [Nfasc186 and Nfasc155, re-
spectively (Sherman et al., 2005)] demonstrated that in some
cases these P-mTOR accumulations were associated with nodes
of Ranvier but were also occasionally localized adjacent to the
Schmidt-Lanterman incisura of the surrounding Schwann cells
(Fig. 5F). Generally, the cytoplasmof Schwanncells stainedpositive
for P-mTOR. Finally, P-mTOR staining in sensory axons could not
be tracedbeyond thedorsal root entry zone (Fig. 5G). Therefore, not
surprisingly, double staining spinal cord
sections for P-mTOR and synaptophysin,
synapsin, or VGLUT1 did not show local-
ization of mTOR in axon terminals (results
not shown).
Immunohistochemical staining of sec-
tions of adult rat dorsal roots indicated
that P-S6 and P-4EBP1/2 followed the
same pattern of expression as P-mTOR
(Fig. 6).
Intrathecal administration of
rapamycin blocks mTORC1 activity in
the dorsal roots but not in DRGs
Activity of mTORC1 was assessed by quan-
tifying phosphorylation of the downstream
target S6 protein. Animals received an in-
trathecal injection of the mTORC1 in-
hibitor rapamycin or vehicle. Tissue was
taken 2 h after the intrathecal injection.
UsingWestern blotting, we found that in-
trathecal injections of rapamycin reduced
phosphorylation of S6 in dorsal roots
(supplemental Fig. S2A, available at www.
jneurosci.org as supplemental material)
(100 29% vs 23 12%, vehicle vs rapa-
mycin; p 0.05) but not in DRGs (supple-
mentalFig. S2B, available atwww.jneurosci.
org as supplementalmaterial) (100 8%vs
9823%,vehicle vs rapamycin), indicating
that mTORC1 activity was inhibited by
rapamycin only in the dorsal roots.
P-mTOR, P-S6, and P-4EBP1/2 are
strongly expressed in lamina I/III
projection neurons
Having established that rapamycin has a
profound effect on the sensitivity of
subsets of dorsal root fibers, we next
looked at the expression of mTOR in the
dorsal horn, since this compartment is
reached by rapamycin injected intrathe-
cally. P-mTOR, P-S6, and P-4EBP1/2
staining was observed in neuronal and
glial cells (Fig. 7). A striking feature of the
expression of these three phosphorylated
proteins in the superficial dorsal horn was
their dense expression within lamina I/III
neurons, which lead us to investigate their
expression specifically in lamina I/III pro-
jection neurons. Indeed, these projection
neurons have been shown to be key to the
initiation and maintenance of many pain
states (Nichols et al., 1999).
Animals were injected with a retrograde
label (FG) in the parabrachial area and perfused 3 d later. When
spinal cord sections were double-labeled with an antibody against
P-mTOR,P-S6,orP-4EBP1/2andanantibodyagainstFG,we found
that P-mTOR and P-S6 were strongly expressed in lamina I/III pro-
jections neurons (77 3% and 80 1%, respectively;N 3) and
their dendrites (Fig. 7A–E). P-4EBP1/2 staining was intense in den-
drites but at lower levels in cell bodies (Fig. 7F,G).
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Figure6. P-4EBP1/2andP-S6 immunoreactivity indorsal roots is largely foundwithinmyelinated fibers.A–D, Confocal images
of longitudinal sections of dorsal roots. A, Colocalization of P-4EBP1/2 (green) andmyelinated fiber marker N52 (red). B, Colocal-
ization of P-4EBP1/2 (green) and nerve fibersmarker PGP (red). C, Colocalization of P-S6 (green) andmyelinated fibermarker N52
(red).D, Colocalization of P-S6 (green) andnerve fibersmarker PGP (red). P-4EBP1/2 andP-S6 staining canbe seenalong thenerve
fibers but also in accumulations along the fibers. In A–D, the single staining for each antibody and the merged image are shown
from left to right and double staining appears in yellow. A–D, Single plane picture. Scale bars: A–D, 25m.
P-mTOR merged
merged merged merged
fluorogold
B C D
A
mergedfluorogoldP-S6E
F fluorogold mergedP-4EBP1/2
G fluorogold mergedP-4EBP1/2
P-mTOR P-mTOR P-mTOR
Figure 7. P-mTOR, P-S6 protein, and P-4EBP1/2 are strongly expressed in lamina I/III projection neurons. Colocalization of
projection neurons labeled with Fluorogold and an antibody against Fluorogold (red) and (green): A–D, P-mTOR; E, P-S6; and
F, G, P-4EBP1/2. In A, E–G, the single staining for each antibody and the merged image are shown from left to right and double
staining appears in yellow.Notice the extensive staining of dendrites (arrowheads)marked onmergedpictures. The percentage of
projections neurons labeled with P-mTOR and P-S6 was, respectively: 77 3% and 80 1%; B–D show the merged pictures.
Arrows show double labeled neurons. Scale bars: A–C, 100m; D–G, 25m.
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Intrathecal administration of rapamycin blocks mTORC1
activity in the dorsal horn
Activity of mTORC1 in the spinal cord was assessed by quantify-
ing phosphorylation of the downstream targets 4E-BP1/2 and S6
protein. As above, animals received an intrathecal injection of the
mTORC1 inhibitor rapamycin or vehicle. Using Western blot-
ting, we found that intrathecal injections of rapamycin reduced
phosphorylation of downstream targets of mTORC1. Specifi-
cally, Western blot analysis showed a significant decrease in 4E-
BP1/2 phosphorylation in the dorsal horn 30 min after injection
of rapamycin compared to vehicle (supplemental Fig. S3, avail-
able at www.jneurosci.org as supplemental material) (p 0.05).
There was also a significant decrease in S6 phosphorylation in the
dorsal horn in the rapamycin-treated group when compared to
vehicle at 2 h after treatment but not at 30min (Fig. 8) (p 0.05).
The number of P-S6 protein expressing cells increases in the
superficial dorsal horn after capsaicin administration,
especially in lamina I, and rapamycin can attenuate this effect
To investigate the influence of noxious stimulation onmTORC1
activity in dorsal horn neurons, we measured the effect of in-
traplantar injection of capsaicin on the phosphorylation of
mTORC1 downstream target S6. Two hours after capsaicin ad-
ministration there was a significant increase in the number of
neurons expressing P-S6 protein, specifically in lamina I/II
(176.8% increase, ipsi vs contra) and lamina V-VI (136.5% in-
crease, ipsi vs contra) (P 0.01 in both areas) (supplemental Fig.
S4, available at www.jneurosci.org as supplemental material, and
Fig. 9A).
We repeated the experiment but this time animals were sepa-
rated in two groups receiving an intrathecal injection of rapamy-
cin or vehicle 4 h before the injection of capsaicin. Rapamycin
significantly reduced the expression of P-S6 protein in the dorsal
horn across all superficial dorsal horn domains. Moreover, the
level of P-S6 protein on the ipsilateral side was comparable to the
contralateral side (Fig. 9B,C).
This experiment demonstrates that capsaicin stimulation ac-
tivates mTORC1 signaling in the dorsal horn and that this is
sensitive to rapamycin inhibition.
mTOR activity in the dorsal roots and in the superficial dorsal
horn does not change 7 d after SNI surgery
We assessed mTOR activity after SNI by measuring P-S6 expres-
sion in the dorsal roots (by Western blot analysis, N 4) and in
the dorsal horn (by immunohistochemistry,N 3, and byWest-
ern blot analysis, N  6), 7 d following SNI (or sham) surgery.
There was no difference in P-S6 expression in the dorsal roots or
spinal cord, compared to sham or the contralateral side (supple-
mental Fig. S5, available at www.jneurosci.org as supplementalma-
terial). Finally, our observations of dorsal roots 7 d after SNI surgery
showed that P-mTOR expression remained largely restricted to
A-fibers and there was no new expression of the translational
machinery within small fibers; indeed, the percentage of
peripherin-labeled fibers expressing P-mTOR did not change af-
ter SNI (3.8  0.13 and 3.9  0.08, ipsi vs contra respectively).
We interpret this to mean that following SNI surgery, increased
pain sensitivity is not driven by amaintained increase in axonal or
dorsal horn neuron mTOR activity.
Discussion
Chronicpain,particularlyneuropathicpain inhumans, isdifficult to
manage with current therapeutic approaches (Breivik et al., 2006).
Here, we show that central application of rapamycin, which inhibits
mTORC1-regulated protein synthesis, attenuates persistent pain
states in rats.Wedemonstrate that this effect ismediatedbyblocking
mTORC1activity inperipheralA-fibers and central neurons, specif-
ically a subset of primary afferent A-nociceptors and lamina I/III
dorsalhornprojectionneurons that conveynociceptive information
to thebrain.Rapamycin, at this concentration, hadnoobvious effect
on the physiology of C-fibers or other capsaicin-sensitive sensory
afferents. These findings suggest a new pharmacological route for
therapeutic intervention in chronic pain.
mTOR in sensory nerve fibers
We have shown that P-mTOR is expressed in a subset of dorsal
root fibers, the majority of which are A-fibers, although we also
noted a small number of peripherin-positive fibers, some of
which may be C-fibers (Fig. 5D,E). Indeed, peripherin labels the
majority of C-fibers but some coexpression with small diameter
N52-positive neurons has been reported (Ferri et al., 1990). This
extends previous observations that P-eIF-4E, ribosomal protein
P0, and components of the degradative machinery, 20S proteo-
some core, ubiquitin, and ubiquinated proteins are also found in
myelinated dorsal root axons (Koenig et al., 2000; Verma et al.,
2005). By monitoring the activation state of one of mTORC1
downstream target proteins, S6, we show that intrathecally ad-
ministered rapamycin will reach the dorsal roots but that within
the time scale used here does not affect phosphorylation of S6 in
the DRGs.We have previously observed a similar reduction in S6
phosphorylation inmyelinated axons following rapamycin injec-
tions into cutaneous tissue. Our in vitro studies of dorsal roots
incubated in low-dose rapamycin indicate that while amplitude
and conduction velocity are not changed, rapamycin increases
the activation threshold of A-fibers. Finally, we show that the
thermal sensitivity of capsaicin-insensitive A-fibers decrease
following rapamycin, while C-fiber responses remain unaffected
by rapamycin at this concentration. These data support previous
evidence that the sensitivity of a subset of A-nociceptors is main-
tained by tonic activity in themTORC1 signaling pathway. Rapa-
mycin treatment inhibits mTOR signaling and reduces the
response of A-nociceptors resulting in both blunted secondary
hyperalgesia and decreased mechanical sensitivity in a model of
neuropathic pain (Jime´nez-Díaz et al., 2008).
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Figure 8. Intrathecal administration of rapamycin decreases phosphorylation of the down-
stream target ofmTORC1 S6protein (S6) in the spinal cord. Immunoblots probedwith anti-P-S6
antibody and anti-S6 antibody after gel electrophoresis of lysates from spinal cord tissue. Ani-
mals received an intrathecal injection of rapamycin or vehicle 30min or 2 h before killing. There
was a significant reduction in S6 phosphorylation 2 h after rapamycin injection in spinal cord
tissue. N 3–4 in each condition. Mean SEM is illustrated. *p 0.05.
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The present data show that mTORC1 signaling pathway
maintains the sensitivity of a subset of A-nociceptors. Rapamycin
treatment selectively increased the stimulation intensity required
to elicit the A-component of extracellularly recorded com-
pound action potentials from isolated dorsal roots. Inmyelinated
axons, voltage-gated sodium channels, which are essential for
action potential generation and propagation, are clustered in
high densities at nodes of Ranvier, whereas voltage-gated potas-
sium channels are found both at the node of Ranvier and at
juxtaparanodes (Rasband and Trimmer, 2001; Vacher et al.,
2008). The “threshold” or amount of current required to drive
the membrane potential to the threshold for eliciting an action
potential will be regulated by the proportions and different types
of these voltage-gated channels present. Therefore, it would seem
likely that mTORC1-mediated local translation regulates the
function, expression, or localization of particular voltage-gated
channels, which maintain the sensitivity of A-fibers under nor-
mal conditions. Interestingly, activation of mTOR has been shown
to suppress potassium channel Kv1.1 expression in dendrites (Raab-
Graham et al., 2006), which would in turn increase excitability, and
this channel is expressed in peripheral myelinated axons at jux-
taparanodes (Rasband et al., 1998). Other voltage-gated channels
present in peripheral myelinated axons include Nav1.6 (Caldwell et
al., 2000), Kv7.2 (Devaux et al., 2004), and Kv1.2 (Rasband et al.,
1998) although it is unclear whether mRNAs for these different
channel proteins are transported in sensory nerves.
Unexpectedly, while we were able to localize P-mTOR to dor-
sal root fibers, wewere unable to trace these labeled fibers into the
dorsal horn. Close examination and double labeling with a range
of synaptic markers revealed that P-mTOR immunoreactivity in
axons did not extend beyond the dorsal root entry zone and raises
the possibility that local translation in sensory axons requires an
environment unique to the peripheral nervous system. One sug-
gestion is that local translation is modu-
lated by Schwann cells, glial cells found
only in peripheral nervous system. In this
respect it has recently been suggested that
ribosomes and associated mRNA may be
transferred from Schwann cells to axons
(Court et al., 2008). The route for this trans-
fer is unknown but may be through
Schmidt-Lanterman incisura (SLI), which
are formed fromstrands of Schwanncell cy-
toplasm and pass through the compactmy-
elin to the adaxonal surface of the axon. The
SLI have high levels of P-mTOR, suggesting
that ribosomal subunitsmay be synthesized
in the incisura adjacent to local accumula-
tions of axonal mTOR.
Rapamycin effects on the dorsal horn
Ourresults clearly indicate that intrathecally
administered rapamycin can influence pain
response by acting on A-fibers in dorsal
roots.However, there have also been several
reports that late phase of the formalin re-
sponse is attenuated by intrathecal rapamy-
cin (Price et al., 2007; Asante et al., 2009),
with the implication that this reflects adirect
effect of rapamycin on spinal neurons. Al-
though our understanding of the formalin
response is far fromclear, with both periph-
eral and central mechanisms being invoked
to explain the second phase of the response (Puig and Sorkin, 1996;
De Felipe et al., 1998; McNamara et al., 2007), dorsal horn mecha-
nisms are likely to contribute to the changes in persistent pain
thresholds seen after intrathecal administration of rapamycin. In-
deed, targets ofmTORC1 signaling such as S6 are rapidly phosphor-
ylated in neurons throughout the dorsal horn, following peripheral
capsaicin stimulation that activates largely small diameter C-fibers,
and this is inhibited by intrathecal rapamycin.
Immunohistochemically, we noted that lamina I projection
neurons and their dendrites were strongly P-mTOR, P-S6 and
P-4EBP1/2 positive. Lamina I projection neurons receive inputs
from A-nociceptors (Torsney and MacDermott, 2006) and are
essential for the development and maintenance of both neuro-
pathic and inflammatory pain states (Mantyh et al., 1997;Nichols
et al., 1999). It seems likely that some of these A-nociceptors may
indeed include those in which mTOR-regulated control of sensi-
tivity is present. mTOR has been shown to be essential for local
translation in hippocampal neuron dendrites and for the gener-
ation of late long-term potentiation (L-LTP). Indeed, hippocam-
pal late (but not early) LTP requires activation of downstream
targets of mTORC1, 4E-BP1/2, and S6K, and this is correlated
with an increase in TOPmRNAs expression.mTORhas also been
shown to be essential for the formation and stability of learning
and memory in the amygdala and the hippocampus (Tang et al.,
2002; Parsons et al., 2006; Costa-Mattioli et al., 2009). Lamina I
projection neurons also support LTP following low-frequency,
high-intensity stimulation of the peripheral nerve (Ikeda et al.,
2003; Ikeda et al., 2006). Therefore, it appears likely that the
attenuation by rapamycin of the increasedmechanical sensitivity
that follows capsaicin injection could partly be a reflection of the
attenuation of LTP-like events in lamina I neurons.However, this
is unlikely to be the case after peripheral nerve damage. Indeed,
electrophysiological studies have shown that rapamycin is only
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Figure 9. Intrathecal administration of rapamycin reduces the capsaicin-induced increase in phosphorylation of S6 protein in
the spinal cord.A, Confocal imagesof P-S6 immunostaining in the superficial dorsal horn2hafter intraplantar injectionof capsaicin
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effective at inhibiting hippocampal L-LTP when present during
the induction phase of LTP and that later application of rapamy-
cin is without effect (Cammalleri et al., 2003). If the effect of
rapamycin on dorsal horn contributes to the inhibition of the
increased mechanical sensitivity seen after SNI, this would indi-
cate that the effect of rapamycin on lamina I projection neurons is
independent of LTP- like phenomena or that the mechanism of
LTP in lamina I is different from that in the hippocampus.More-
over, we also investigated mTOR activity in the superficial dorsal
horn 7 d following SNI surgery: there was no difference in P-S6
expression in the spinal cord or dorsal roots, compared to both
sham or the contralateral side (supplemental Fig. S5, available at
www.jneurosci.org as supplemental material). Together with a
previous report showing that the dorsal roots A-fiber thresholds
and conduction velocities are unchanged after SNI surgery
(Kohno et al., 2003), we interpret this tomean that increased pain
sensitivity in SNI is not driven by amaintained increase in axonal
or dorsal horn neuron mTOR activity.
Lamina I projection neurons are thought to control spinal excit-
ability through the engagement of descending pathways at brain-
stem levels (Hunt, 2000; Suzuki et al., 2002). Of particular relevance
to the present study is the suggestion that these descending controls
largely regulate secondary hyperalgesia (Pertovaara, 1998; Urban
andGebhart, 1999; Sanoja et al., 2009), that is, the pain sensitivity
that develops in the undamaged skin around an injury and which
can be alleviated by rapamycin given peripherally or centrally.
Moreover, the increased mechanical sensitivity that defines sec-
ondary hyperalgesia is also characteristic of neuropathic pain and
specific lesions of lamina I neurons alleviate both experimentally
induced pain states underlining the mechanistic similarities be-
tween the two conditions (Mantyh et al., 1997; Nichols et al.,
1999). However, complete loss of lamina I projection neurons
does have a more widespread influence on pain processing than
rapamycin application. Indeed, injection of capsaicin into the rat
hindpaw results in prolonged thermal and mechanical hyperal-
gesia, both of which are reduced by lesions of lamina I neurons
(Mantyh et al., 1997), while rapamycin had no effect on thermal
thresholds after capsaicin treatment. This suggests a more specific
effect of rapamycin onmechanical sensitivity.
The substantial reduction in neuropathic pain sensitivity by
rapamycin may also reflect an action on non-neuronal cells that
hypertrophy following peripheral nerve damage. Signaling of the
mTORC1 pathway has been shown to be upregulated in astro-
cytes following direct damage to the spinal cord (Codeluppi et al.,
2009). Moreover, astrocytic hypertrophy could be inhibited by
rapamycin in vitro, while in vivo rapamycin reduced reactive gli-
osis suggesting that this drug could be used to reduce astrocytic
response (Codeluppi et al., 2009). Astrocytic response during
neuropathic pain has been shown to contribute to increased
sensitivity (Gao et al., 2009; Kim et al., 2009) and activated
microglia release factors that maintain neuropathic sensitivity
(Inoue and Tsuda, 2009). P-mTOR, P-S6, and P-4EBP1/2
were expressed in astrocytes on the side ipsilateral to periph-
eral nerve damage but also on the contralateral side and in
naive tissue (supplemental Fig. S6, available at www.jneurosci.
org as supplemental material). However, we did not find any
evidence for increased activation of mTOR in dorsal horn
astrocytes or microglia 7 d after SNI. Thus, there was no in-
crease in glial expression of phoshorylated translational mark-
ers following peripheral nerve damage. This was supported by
our Western and immunohistochemical analysis of mTOR
activity 7 d after SNI (supplemental Fig. S5, available at www.
jneurosci.org as supplemental material). Nevertheless, we can-
not rule out the possibility that intrathecally administered
rapamycinmay influence astrocytes in the superficial dorsal horn
and contribute to the reduction in neuropathic pain sensitivity
described in the present study.
In summary, our results suggest that increased sensitivity
around the site of injury, which is essential for the prevention of
further damage and healing, is communicated by a dedicated
subset of mTOR-positive A-nociceptors that may synapse with
lamina I projection neurons, which are also characterized by high
levels ofmTORC1 activity.Wepresent evidence to show that rapa-
mycin, an inhibitor of mTORC1 signaling, generates a profound
anti-nociceptive effect specifically on the spread of pain outside of
the area of injury and on neuropathic pain sensitivity.We show that
this is mediated by a direct action on dorsal root fibers and possibly
on dorsal horn neurons and suggest that rapamycin treatment may
offer hope for the treatment of intractable pain states.
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